The atom‐transfer radical polymerization (ATRP) of acrylates in 1‐butyl‐3‐methylimidazolium hexafluorophosphate was investigated. The solubility of the acrylates in the ionic liquid depends on the substituent. The homogeneous polymerization of methyl acrylate gives polymers with M̄n close to the calculated value and relatively narrow polydispersity. In heterogeneous polymerizations of higher acrylates, with the catalyst present in the ionic liquid phase, deviations from ideal behavior are observed although the polymerization of butyl acrylate approaches the conditions of a controlled polymerization.
Polymerization of epichlorohydrin (ECH) in the presence of diols, catalyzed by Lewis or protic acids, proceeds by activated monomer mechanism (AMM), i.e., by subsequent additions of protonated monomer molecules to the terminal hydroxyl groups of the growing chain. As opposed to the typical active chain end mechanism, side reactions, including cyclization, are strongly suppressed in the polymerization by AMM and well‐defined linear product are obtained. It follows from kinetic considerations, that in order to achieve the high contribution of AMM, the reaction should be carried out at low instantaneous concentration of monomer, and this can be accomplished by slowly adding ECH to the reaction mixture. Using this approach, polyepichlorophydrin diols have been prepared in the M̄n ∼ 2500 products with DPn = [M]0/[I]0 can be obtained practically free of cyclic by‐products with the yields approaching quantitative. Polyepichlorohydrin diols obtained by AM polymerization are strictly bifunctional, regular head‐to‐tail polymers containing mainly (≥ 95%) secondary hydroxyl and groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.